These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33040583)

  • 21. The relation between apolipoprotein E (APOE) genotype and peripheral artery disease in patients at high risk for cardiovascular disease.
    Koopal C; Geerlings MI; Muller M; de Borst GJ; Algra A; van der Graaf Y; Visseren FL;
    Atherosclerosis; 2016 Mar; 246():187-92. PubMed ID: 26800308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.
    Verma S; Mazer CD; Al-Omran M; Inzucchi SE; Fitchett D; Hehnke U; George JT; Zinman B
    Circulation; 2018 Jan; 137(4):405-407. PubMed ID: 29133602
    [No Abstract]   [Full Text] [Related]  

  • 23. Evolution and degree of control of cardiovascular risk factors after 5 years of follow-up and their relationship with the incidence of peripheral arterial disease: ARTPER cohort.
    Forés R; Alzamora MT; Pera G; Valverde M; Angla M; Baena-Díez JM; Mundet-Tuduri X
    Med Clin (Barc); 2017 Feb; 148(3):107-113. PubMed ID: 27894602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral Arterial Disease and Cardiovascular Risk: The Role of Mediterranean Diet.
    Chrysohoou C; Esposito K; Giugliano D; Panagiotakos DB
    Angiology; 2015 Sep; 66(8):708-10. PubMed ID: 25354501
    [No Abstract]   [Full Text] [Related]  

  • 26. Amputation trends for patients with lower extremity ulcers due to diabetes and peripheral artery disease using statewide data.
    Humphries MD; Brunson A; Li CS; Melnikow J; Romano PS
    J Vasc Surg; 2016 Dec; 64(6):1747-1755.e3. PubMed ID: 27670653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study.
    Malmstedt J; Kärvestedt L; Swedenborg J; Brismar K
    Cardiovasc Diabetol; 2015 Jul; 14():93. PubMed ID: 26216409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addressing disparities in chronic limb-threatening ischemia care: What are we waiting for?
    Klein AJ; Hawkins BM
    Vasc Med; 2021 Apr; 26(2):123-125. PubMed ID: 33606966
    [No Abstract]   [Full Text] [Related]  

  • 29. Galectin-3 is not predictive of cardiovascular events in patients with peripheral artery disease.
    Blinc A; Šabovič M; Kšela J; Puščenik L; Perme MP; Mijovski MB
    Vasa; 2021 Apr; 50(3):244-245. PubMed ID: 33559502
    [No Abstract]   [Full Text] [Related]  

  • 30. Peripheral arterial testing before lower extremity amputation among Medicare beneficiaries, 2000 to 2010.
    Vemulapalli S; Greiner MA; Jones WS; Patel MR; Hernandez AF; Curtis LH
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):142-50. PubMed ID: 24425703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western Denmark Heart Registry.
    Olesen KKW; Gyldenkerne C; Thim T; Thomsen RW; Maeng M
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33414173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease.
    Giugliano G; Di Serafino L; Perrino C; Schiano V; Laurenzano E; Cassese S; De Laurentis M; Schiattarella GG; Brevetti L; Sannino A; Gargiulo G; Franzone A; Indolfi C; Piscione F; Trimarco B; Esposito G
    Int J Cardiol; 2013 Sep; 167(6):2566-71. PubMed ID: 22790191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single and combined effects of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events: A prospective cohort study.
    Saely CH; Schindewolf M; Zanolin D; Heinzle CF; Vonbank A; Silbernagel G; Leiherer A; Drexel H; Baumgartner I
    Atherosclerosis; 2018 Dec; 279():32-37. PubMed ID: 30399464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review and meta-analysis of gender differences in long-term mortality and cardiovascular events in peripheral artery disease.
    Parvar SL; Thiyagarajah A; Nerlekar N; King P; Nicholls SJ
    J Vasc Surg; 2021 Apr; 73(4):1456-1465.e7. PubMed ID: 33161072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Risk Stratification in Patients with Femoropopliteal PAD. Can We Fight Against the Poor Prognosis?
    Tsubakimoto Y
    J Atheroscler Thromb; 2021 Nov; 28(11):1128-1129. PubMed ID: 33883346
    [No Abstract]   [Full Text] [Related]  

  • 36. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
    Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Reid CM; Baumgartner I; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
    Clin Cardiol; 2017 Sep; 40(9):710-718. PubMed ID: 28520087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease.
    Armstrong EJ; Anderson DR; Yeo KK; Singh GD; Bang H; Amsterdam EA; Freischlag JA; Laird JR
    J Vasc Surg; 2015 Jul; 62(1):157-165.e1. PubMed ID: 25864042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.
    Kaplovitch E; Eikelboom JW; Dyal L; Aboyans V; Abola MT; Verhamme P; Avezum A; Fox KAA; Berkowitz SD; Bangdiwala SI; Yusuf S; Anand SS
    JAMA Cardiol; 2021 Jan; 6(1):21-29. PubMed ID: 32997098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lower limb peripheral arterial disease in 268 patients in Guadeloupe].
    Bélaye L; Lurel D; Ezelin F; Cassin F; Lutin J; Porcène JA; Helissey P; Blanchet-Deverly A
    J Mal Vasc; 2016 Jul; 41(4):246-52. PubMed ID: 27289257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated cardiac troponin T is associated with higher mortality and amputation rates in patients with peripheral arterial disease.
    Linnemann B; Sutter T; Herrmann E; Sixt S; Rastan A; Schwarzwaelder U; Noory E; Buergelin K; Beschorner U; Zeller T
    J Am Coll Cardiol; 2014 Apr; 63(15):1529-38. PubMed ID: 23792625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.